Evidence map›Paper›PMID 24905922›Full record

ArticlePloS one2014

Comparative analysis of gene expression data reveals novel targets of senescence-associated microRNAs.

Marco Napolitano, Marika Comegna, Mariangela Succoio, Eleonora Leggiero, Lucio Pastore, Raffaella Faraonio, Filiberto Cimino, Fabiana Passaro

Open access · goldAbstract readComparative Study
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Implications of Cellular Aging in Cardiac Reprogramming.Frontiers in cardiovascular medicine · 2018
    Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marco NapolitanoIRCCS SDN Foundation, Naples, Italy.
Marika ComegnaDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy; CEINGE - Advanced Biotechnologies, Naples, Italy.
Mariangela SuccoioDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy; CEINGE - Advanced Biotechnologies, Naples, Italy.
Eleonora LeggieroCEINGE - Advanced Biotechnologies, Naples, Italy.
Lucio PastoreDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy; CEINGE - Advanced Biotechnologies, Naples, Italy.
Raffaella FaraonioDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy; CEINGE - Advanced Biotechnologies, Naples, Italy.
Filiberto CiminoIRCCS SDN Foundation, Naples, Italy; Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy; CEINGE - Advanced Biotechnologies, Naples, Italy.
Fabiana PassaroDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy; CEINGE - Advanced Biotechnologies, Naples, Italy.
University of Naples Federico II · ITCeinge Biotecnologie Avanzate (Italy) · ITSDN Istituto di Ricerca Diagnostica e Nucleare · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last decades, cellular senescence is viewed as a complex mechanism involved in different processes, ranging from tumor suppression to induction of age-related degenerative alterations. Senescence-inducing stimuli are myriad and, recently, we and others have demonstrated the role exerted by microRNAs in the induction and maintenance of senescence, by the identification of a subset of Senescence-Associated microRNAs (SAmiRs) up-regulated during replicative or stress-induced senescence and able to induce a premature senescent phenotype when over-expressed in human primary cells. With the intent to find novel direct targets of two specific SAmiRs, SAmiR-494 and -486-5p, and cellular pathways which they are involved in, we performed a comparative analysis of gene expression profiles available in literature to select genes down-regulated upon replicative senescence of human primary fibroblasts. Among them, we searched for SAmiR's candidate targets by analyzing with different target prediction algorithms their 3'UTR for the presence of SAmiR-binding sites. The expression profiles of selected candidates have been validated on replicative and stress-induced senescence and the targeting of the 3'UTRs was assessed by luciferase assay. Results allowed us to identify Cell Division Cycle Associated 2 (CDCA2) and Inhibitor of DNA binding/differentiation type 4 (ID4) as novel targets of SAmiR-494 and SAmiR-486-5p, respectively. Furthermore, we demonstrated that the over-expression of CDCA2 in human primary fibroblasts was able to partially counteract etoposide-induced senescence by mitigating the activation of DNA Damage Response.

Indexed as

Gene Expression ProfilingCarrier ProteinsCell CycleCell Cycle ProteinsCellular SenescenceDown-RegulationFibroblastsHEK293 CellsHumansInhibitor of Differentiation ProteinsMicroRNAsNuclear ProteinsCarrier ProteinsCDCA2 protein, humanCell Cycle ProteinsID4 protein, humanInhibitor of Differentiation ProteinsMicroRNAsNuclear Proteins

Identifiers

PMID24905922
PMCPMC4048207
OpenAlexW1998689684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.